{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:16:49Z","timestamp":1788236209950,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","award":["NRPU 1509"],"award-info":[{"award-number":["NRPU 1509"]}],"id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.heliyon.2019.e01552","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T20:55:18Z","timestamp":1556398518000},"page":"e01552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Coumarin derivatives as acetyl- and butyrylcholinestrase inhibitors: An in\u00a0vitro, molecular docking, and molecular dynamics simulations study"],"prefix":"10.1016","volume":"5","author":[{"given":"Marwa N.","family":"Abu-Aisheh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Al-Aboudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"El-Abadelah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman Yousuf","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8530-8711","authenticated-orcid":false,"given":"Zaheer","family":"Ul-Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2019.e01552_bib1","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3390\/12092130","article-title":"Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa","volume":"12","author":"Jung","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2019.e01552_bib2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fphar.2018.01192","article-title":"Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer's disease therapy","volume":"9","author":"dos Santos","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01552_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1023\/A:1011963929012","article-title":"Advances and challenges in the prevention and treatment of Alzheimer's disease","volume":"15","author":"Brinton","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.heliyon.2019.e01552_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/14756360802236393","article-title":"Butyrylcholinesterase inhibitory activity of testosterone and some of its metabolites","volume":"24","author":"Al-Aboudi","year":"2009","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/ph4020382","article-title":"Neuroactive multifunctional tacrine congeners with cholinesterase, anti-amyloid aggregation and neuroprotective properties","volume":"4","author":"Kozurkova","year":"2011","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.heliyon.2019.e01552_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/717232","article-title":"Acetylcholinesterase and butyrylcholinesterase inhibitory activities of \u0392-carboline and quinoline alkaloids derivatives from the plants of genus Peganum","volume":"2013","author":"Zhao","year":"2013","journal-title":"J. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1399-6576.1961.tb00083.x","article-title":"Potentiation of the neuromuscular effect of succinylcholine by tetrahydro-amino-acridine","volume":"5","author":"Gordh","year":"1961","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.heliyon.2019.e01552_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mehy.2007.04.035","article-title":"Rationale for diagnosing deficiency of chesond for applying exogenous huches to the treatment of diseases","volume":"70","author":"Shen","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.heliyon.2019.e01552_bib9","first-page":"262","article-title":"Synthesis and evaluation of acetylcholineesterase inhibitory potential and antioxidant activity of benzothiazine derivatives","volume":"37","author":"Shahwar","year":"2013","journal-title":"Turk. J. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2174\/092986708784310422","article-title":"Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update","volume":"15","author":"Loizzo","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2174\/1385272820666160601155411","article-title":"Coumarin derivatives in pharmacotherapy of Alzheimer's disease","volume":"21","author":"Hamulakova","year":"2017","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.ejmech.2005.07.014","article-title":"Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors","volume":"40","author":"Shen","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib13","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1016\/j.bmc.2008.07.068","article-title":"Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues","volume":"16","author":"Zhou","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1527-3458.2002.tb00220.x","article-title":"Ensaculin (KA-672. HCl): a multitransmitter approach to dementia treatment","volume":"8","author":"Hoerr","year":"2002","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.heliyon.2019.e01552_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.phrs.2008.08.001","article-title":"Inhibition of acetylcholinesterase by coumarins: the case of coumarin 106","volume":"58","author":"Fallarero","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2019.e01552_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1515\/znc-2008-5-610","article-title":"Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity","volume":"63","author":"Orhan","year":"2008","journal-title":"Z. Naturforsch. C"},{"key":"10.1016\/j.heliyon.2019.e01552_bib17","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1021\/jm049655r","article-title":"Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products","volume":"47","author":"Rollinger","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/oxfordjournals.jbchem.a135599","article-title":"Inhibitory effects of various synthetic substrates for aminopeptidases on phagocytosis of immune complexes by macrophages","volume":"99","author":"Iwaki","year":"1986","journal-title":"J. Biochem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbiopara.2007.11.011","article-title":"Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis","volume":"158","author":"Acosta","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.heliyon.2019.e01552_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ab.2009.01.045","article-title":"Quantitative technique for determining proteases and their substrate specificities and pH optima in crude enzyme extracts","volume":"388","author":"Budi\u010d","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1134\/S1068162008030151","article-title":"Chemoenzymatic synthesis of new fluorogenous substrates for cysteine proteases of the papain family","volume":"34","author":"Semashko","year":"2008","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib22","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.1021\/bi800230m","article-title":"A small molecule, lys-ala-7-amido-4-methylcoumarin, facilitates RNA dimer maturation of a stem-loop 1 transcript in\u00a0vitro: structure-activity relationship of the activator","volume":"47","author":"Chung","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2019.e01552_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002130050265","article-title":"8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A\/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release","volume":"131","author":"Lucas","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.heliyon.2019.e01552_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0009-2797(99)00020-4","article-title":"Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4, 4\u2032-bipyridine and by a coumarin derivative","volume":"119","author":"Simeon-Rudolf","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.heliyon.2019.e01552_bib25","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1021\/jm010894d","article-title":"Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase","volume":"44","author":"Br\u00fchlmann","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/np000441w","article-title":"Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure\u2013activity relationships","volume":"64","author":"Kang","year":"2001","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.heliyon.2019.e01552_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/13880200500382720","article-title":"Coumarins from Peucedanum ostruthium as inhibitors of acetylcholinesterase","volume":"43","author":"Urbain","year":"2005","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.heliyon.2019.e01552_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2007.10.004","article-title":"In\u00a0vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: thin layer chromatography versus microplate methods","volume":"33","author":"Di Giovanni","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.heliyon.2019.e01552_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bmcl.2007.09.100","article-title":"Multi-target-directed coumarin derivatives: hache and bace1 inhibitors as potential anti-Alzheimer compounds","volume":"18","author":"Piazzi","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2019.e01552_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5539\/ijc.v3n4p89","article-title":"Synthesis and fluorogenic properties of some 1-(coumarin-7-yl)-4, 5-dihydro-1, 2, 4-triazin-6 (1H)-ones","volume":"3","author":"Mustafa","year":"2011","journal-title":"Int. J. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib31","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.3390\/molecules16054305","article-title":"Synthesis, and antitumor activity of some N1-(coumarin-7-Yl) amidrazones and related congeners","volume":"16","author":"Mustafa","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2019.e01552_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2019.e01552_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","article-title":"AMBER, A package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules","volume":"91","author":"Pearlman","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.heliyon.2019.e01552_bib34","series-title":"Amber 14 Reference Manual","author":"Case","year":"2014"},{"key":"10.1016\/j.heliyon.2019.e01552_bib35","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.heliyon.2019.e01552_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/07391102.1999.10508297","article-title":"A modified version of the Cornell et\u00a0al. force field with improved sugar pucker phases and helical repeat","volume":"16","author":"Cheatham","year":"1999","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2019.e01552_bib37","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.heliyon.2019.e01552_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.heliyon.2019.e01552_bib39","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2019.e01552_bib40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-59745-177-2_19","article-title":"Molecular docking","volume":"443","author":"Morris","year":"2008","journal-title":"Mol. Model. Proteins"},{"key":"10.1016\/j.heliyon.2019.e01552_bib41","series-title":"Molecular Operating Environment (MOE), 2013.08","year":"2017"},{"key":"10.1016\/j.heliyon.2019.e01552_bib42","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.3390\/md12042114","article-title":"Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-\u03b2 aggregation inhibitors","volume":"12","author":"Stoddard","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.heliyon.2019.e01552_bib43","first-page":"59","article-title":"2-(2-(4-Benzoylpiperazin-1-yl) ethyl) isoindoline-1, 3-dione derivatives: synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-Alzheimer agents","volume":"20","author":"Mohammadi-Farani","year":"2017","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.heliyon.2019.e01552_bib44","doi-asserted-by":"crossref","first-page":"77431","DOI":"10.1039\/C6RA12507G","article-title":"Functionalised dihydroazo pyrimidine derivatives from Morita\u2013Baylis\u2013Hillman acetates: synthesis and studies against acetylcholinesterase as its inhibitors","volume":"6","author":"Reddy","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2019.e01552_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.drudis.2016.11.001","article-title":"Molecular dynamics-driven drug discovery: leaping forward with confidence","volume":"22","author":"Ganesan","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2019.e01552_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10822-016-0005-2","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations","volume":"31","author":"Liu","year":"2017","journal-title":"J. Comput. Aided Mol. Des."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844018349302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844018349302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:38:00Z","timestamp":1762511880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844018349302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2405844018349302"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01552","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin derivatives as acetyl- and butyrylcholinestrase inhibitors: An in\u00a0vitro, molecular docking, and molecular dynamics simulations study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01552"}}